16 drugs that have been pulled off the market in the last few years!

And they complain when anyone gets a temporary headache when talking herbs!

---

Vioxx. The king of withdrawn drugs and well documented for causing 60,000 fatal heart attacks and strokes and as many as 160,000 heart attacks and strokes all by itself.

Bextra: Similar drug to Vioxx, withdrawn for similar reasons.

Rezulin: Given fast-track approval by the Food and Drug Administration (FDA), Rezulin was linked to 63 confirmed deaths and probably hundreds more. "We have real trouble," a Food and Drug Administration (FDA) physician wrote in 1997, just a few months after Rezulin's approval. The drug wasn't taken off the market until 2000.

Baycol: (made by Bayer AG) - a cholesterol-lowering drug taken by 700,000 Americans - It had been linked to 31 U.S. deaths. At least nine more fatalities abroad are known.

Lotronex: Against concerns of one of its own officers, the Food and Drug Administration (FDA) approved Lotronex in February 2000. By the time it was withdrawn 9 months later, the Food and Drug Administration (FDA) had received reports of 93 hospitalizations, multiple emergency bowel surgeries, and 5 deaths.

Propulsid: A top-selling drug for many years, this drug was linked to hundreds of cases of heart arrhythmias and over 100 deaths.

Redux: Taken by millions of people for weight loss after its approval in April 1996, Redux was soon linked to heart valve damage and a disabling, often lethal pulmonary disorder. Taken off the market in September 1997.

Pondimin: A component of Fen-Phen, the diet fad drug. Approved in 1973, Pondimin's link to heart valve damage and a lethal pulmonary disorder wasn't recognized until shortly before its withdrawal in 1997.

Duract: This painkiller was taken off the market when it was linked to severe, sometimes fatal liver failure.

Seldane: America's and the world's top-selling antihistamine for a decade, it took the Food and Drug Administration (FDA) 5 years to recognize that Seldane was causing cardiac arrhythmias, blackouts, hospitalizations, and deaths, and another 8 years to take it off the market.

Hismanal: Approved in 1988 and soon known to cause cardiac arrhythmias, the drug was finally taken off the market in 1999.

Posicor: Used to treat hypertension, the drug was linked to life-threatening drug interactions and more than 100 deaths.

Raxar: Linked to cardiac toxicities and deaths.

Cylert: FDA received 13 reports of pemoline-associated hepatic failure leading to liver transplantation or death, representing an incidence rate 10 to 25 times greater than that of the general population.

Palladone: Withdrawn due to a high risk of accidental overdose when administered with alcohol.

Tysabri: Was expected to become the world's leading treatment for MS, but was pulled from the market after a patient died from a rare central nervous system infection.

Copyright © 2002
Spiritual Awakening Network is a registered trademark
Spiritual Awakening Network/All rights reserved